ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Forms Office of Combination Products;

January 10, 2003

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

Grant Applications Pour Into NCI, NIH; Downward Trend In Funding Due To Be Reversed In FY 1979

June 16, 1978

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997